Jennifer Raoul PhD

Senior Counsel

Executive Summary

Jennifer Raoul is a registered Canadian patent agent in both our Intellectual Property and Technology Professional Group and our National Biotech and Pharmaceutical Group. Based in Ottawa, Jennifer specializes in the drafting and prosecution of patent applications relating to life sciences and chemistry, with particular emphasis on pharmaceuticals, biotechnology and diagnostics. Jennifer works with clients in both the private and public sectors, including life sciences companies of all sizes, from start-ups to global organizations.

Jennifer obtained the highest overall national standing in the four patent agent qualifying examinations, as well as the highest national standing in the patent drafting examination, in her qualifying year.

Jennifer’s PhD research involved experimentation in the areas of in vitro and in vivo pharmacology, therapeutics, cell signalling, immunology, organic chemistry, and molecular biology. During her graduate training, she conducted an Industrial Research Rotation at a global pharmaceutical company.

Representative Work

  • Drafting and prosecuting patent applications in fields related to pharmaceuticals, biotechnology, therapeutics, diagnostics, medical devices, and chemistry.
  • Advising on patentability, validity, infringement, and freedom-to-operate issues.
  • Providing IP due diligence and IP litigation support.
  • Advising on issues related to patented medicines marketed in Canada.
  • Advising on international patent strategies and portfolio management.
  • Advising and assisting with technology transfer.

Publications & Presentations

  • Co-Author, "Navigating the Patent Prosecution Highway in Canada," Life Sciences Canada, 2014 (with Mark Vickers).
  • ​Author, “Patentability of Diagnostic Methods in the Wake of,” Drug Development & Outsourcing, Contact Canada:  Victoria, 2012.
  • Contributing Author, Biotechnology and Chemical Patent Practice in Canada:  3rd edition, BLG publication, 2011.
  • Author, “Canada Regulatory Regimes; Tips on Regulatory Issues,” Managing Intellectual Property (Life Sciences Supplement), 2011.
  • Author, “The Canadian Patent Register:  Your Shield Against Premature Generic Competition,” Contact Canada:  Victoria, 2010.
  • Author, “Drug Wars:  Pre-empt Premature Generic Market Entry by Getting Your Drug Patents Properly Listed on the Canadian Patent Register,” BLG’s IP Prosecution and Litigation News, 2009.
  • Contributing Author, Biotechnology and Chemical Patent Practice in Canada:  2nd edition, BLG publication, 2008.
  • Contributing Author, Intellectual Property and Related Commercial Litigation in Canada:  3rd edition, BLG publication, 2008.
  • Author, “What’s New for Innovators and Generics in Canada?  Revisiting the Amended Patented Medicines and Data Protection Regulations,” Pharma & BioPharma Canada, Contact Canada:  Victoria, 2008.
  • Author, “Recent Amendments to the PM (NOC) and Data Protection Regulations,” Canadian Biotechnology, Contact Canada:  Victoria, 2007.

Rankings & Recognitions

  • Recognized in the 2019 edition (and since 2015) of Intellectual Asset Magazine's (IAM) Patent 1000 – The World's Leading Patent Practitioners (Patent Prosecution - Recommended).
  • Edward Maybee Award for highest overall national standing in the Canadian patent agent qualifying exam.
  • Marie F. Morency Award for highest national standing in the patent drafting portion of the Canadian patent agent qualifying examination.